DECHRA PHARMACLTS (1PK.SG)

Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

Funds Holding 1PK.SG (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding 1PK.SG BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Get more info on our International short position coverage here

Holder Issuer Net Short Position Position Date Origin
Legg Mason Global Asset Management Trust- QS Global Market Neutral Fund 1PK.SG -4900.0 shares, $-231286.61 2020-12-31 N-PORT

Short Position History (International Only)

Holder Net Short Position Position Date Origin
AHL Partners LLP DECHRA PHARMACEUTICALS 0.52% 2019-04-18 UK
AHL Partners LLP DECHRA PHARMACEUTICALS 0.5% 2019-04-03 UK
AHL Partners LLP DECHRA PHARMACEUTICALS 0.5% 2019-01-29 UK
BlackRock Institutional Trust Company, National Association DECHRA PHARMACEUTICALS 0.6% 2019-01-23 UK
BlackRock Institutional Trust Company, National Association DECHRA PHARMACEUTICALS 0.5% 2019-01-11 UK
BlackRock Institutional Trust Company, National Association DECHRA PHARMACEUTICALS 0.58% 2019-03-06 UK
BlackRock Investment Management (UK) Limited DECHRA PHARMACEUTICALS 0.48% 2016-07-14 UK
BlackRock Investment Management (UK) Limited DECHRA PHARMACEUTICALS 0.47% 2016-03-21 UK
BlackRock Investment Management (UK) Limited DECHRA PHARMACEUTICALS 0.59% 2016-02-26 UK
BlackRock Investment Management (UK) Limited DECHRA PHARMACEUTICALS 0.51% 2016-06-06 UK
BlackRock Investment Management (UK) Limited DECHRA PHARMACEUTICALS 0.6% 2016-02-12 UK
BlackRock Investment Management (UK) Limited DECHRA PHARMACEUTICALS 0.52% 2016-02-05 UK
Merian Global Investors (UK) Limited DECHRA PHARMACEUTICALS 0.5% 2019-10-21 UK
Merian Global Investors (UK) Limited DECHRA PHARMACEUTICALS PLC 0.5% 2019-10-21 UK
Numeric Investors LLC DECHRA PHARMACEUTICALS 0.5% 2018-12-06 UK
Numeric Investors LLC DECHRA PHARMACEUTICALS 0.51% 2018-12-10 UK
Polar Capital LLP DECHRA PHARMACEUTICALS 0.51% 2019-10-15 UK
Polar Capital LLP DECHRA PHARMACEUTICALS PLC 0.51% 2019-10-15 UK
SFM UK Management LLP DECHRA PHARMACEUTICALS 0.62% 2020-01-13 UK
SFM UK Management LLP DECHRA PHARMACEUTICALS PLC 0.62% 2020-01-13 UK
SFM UK Management LLP DECHRA PHARMACEUTICALS 0.57% 2019-11-04 UK
SFM UK Management LLP DECHRA PHARMACEUTICALS PLC 0.57% 2019-11-04 UK
SFM UK Management LLP DECHRA PHARMACEUTICALS 0.81% 2019-11-06 UK
SFM UK Management LLP DECHRA PHARMACEUTICALS PLC 0.81% 2019-11-06 UK
Systematica Investments Limited DECHRA PHARMACEUTICALS 0.5% 2019-01-23 UK
WorldQuant, LLC DECHRA PHARMACEUTICALS 0.5% 2019-04-05 UK

UK Ownership History

Updated daily

Contains transactions from January 1st, 2015 on. This data is

Form Holder Issuer Transaction Date Number of Voting Rights % of Voting Rights
TR-1 (s) Dechra Pharmaceuticals plc 2028-09-16 4,635,273 4.997%
TR-1 Schroders plc Dechra Pharmaceuticals Plc 2026-11-15 6,215,444 7.06%
TR-1 BlackRock, Inc. Dechra Pharmaceuticals PLC 2021-02-23 0 5.49%
TR-1 BlackRock, Inc. Dechra Pharmaceuticals PLC 2021-01-28 0 5.55%
TR-1 BlackRock, Inc. Dechra Pharmaceuticals PLC 2020-12-10 6,042,109 5.58%
TR-1 BlackRock, Inc. Dechra Pharmaceuticals PLC 2020-12-02 5,989,811 5.54%
TR-1 BlackRock, Inc. Dechra Pharmaceuticals PLC 2020-11-30 5,967,949 5.52%
TR-1 Grandeur Peak Global Advisors, LLC Dechra Pharmaceuticals PLC 2020-10-16 3,251,783 3.01%
TR-1 Aggregate of Standard Life Aberdeen plc affiliated investment management entities with delegated voting rights on behalf of multiple managed portfolios Dechra Pharmaceuticals PLC 2020-10-01 7,469,991 6.91%
TR-1 BlackRock, Inc. Dechra Pharmaceuticals PLC 2020-08-17 5,519,202 5.1%
TR-1 BlackRock, Inc. Dechra Pharmaceuticals PLC 2020-06-08 0 0.0%
TR-1 FMR LLC DECHRA PHARMACEUTICALS PLC 2017-05-16 9,310,357 9.99%
TR-1 FMR LLC DECHRA PHARMACEUTICALS PLC 2017-04-19 9,315,883 10.0%
TR-1 Aviva plc & its subsidiaries Dechra Pharmaceuticals plc 2017-02-21 2,982,264 3.2%
TR-1 Aberdeen Asset Managers Limited (and/or acting for its affiliates) as discretionary investment manager on behalf of multiple managed portfolios Dechra Pharmaceuticals PLC 2016-11-07 4,587,651 4.94%
TR-1 Kames Capital Plc Dechra Pharmaceuticals PLC 2016-05-12 3,005,455 3.24%
TR-1 Legal & General Group Plc (L&G) Dechra Pharmaceuticals Plc 2015-10-27 0 3.0%
TR-1 Norges Bank Dechra Pharmaceuticals Plc 2015-07-15 2,597,090 2.95%
TR-1 BlackRock, Inc. Dechra Pharmaceuticals PLC 2015-06-24 4,718,260 5.36%
TR-1 BlackRock, Inc. Dechra Pharmaceuticals PLC 2015-05-01 4,439,085 5.04%
TR-1 Schroders plc Dechra Pharmaceuticals plc 2002-08-16 4,540,000 4.895%
TR-1 Dechra Pharmaceuticals PLC 0 5.5%
Holdings in Company Dechra Pharmaceuticals plc 0 0%
Holdings in Company Dechra Pharmaceuticals PLC 0 0%
Holdings in Company Dechra Pharmaceuticals PLC 0 0%
Holdings in Company Dechra Pharmaceuticals PLC 0 0%
Holdings in Company Dechra Pharmaceuticals PLC 0 0%
Holdings in Company Dechra Pharmaceuticals plc 0 0%
TR-1 Kames Capital Plc . 3,069,152 2.98%
Holdings in Company Dechra Pharmaceuticals plc 0 0%
Holdings in Company Dechra Pharmaceuticals plc 0 0%
TR-1 Dechra Pharmaceuticals PLC 0 5.53%
Holdings in Company Dechra Pharmaceuticals PLC 0 0%
Holdings in Company Dechra Pharmaceuticals plc 0 0%
Dechra Pharmaceuticals PLC 0 0%
TR-1 Kames Capital Plc . 3,077,319 2.99%
Dechra Pharmaceuticals PLC 0 0%
Holdings in Company Dechra Pharmaceuticals plc 0 0%
Holdings in Company Dechra Pharmaceuticals PLC 0 0%
TR-1 Dechra Pharmaceuticals PLC 0 5.52%
Holdings in Company DECHRA PHARMACEUTICALS PLC 0 0%
Holdings in Company Dechra Pharmaceuticals PLC 0 0%
Holdings in Company Dechra Pharmaceuticals PLC 0 0%
Holdings in Company Dechra Pharmaceuticals PLC 0 0%
Holdings in Company Dechra Pharmaceuticals PLC 0 0%
Holdings in Company Dechra Pharmaceuticals plc 0 0%
Holdings in Company Dechra Pharmaceuticals plc 0 0%
Holdings in Company Dechra Pharmaceuticals plc 0 0%
Holdings in Company Dechra Pharmaceuticals PLC 0 0%
Holdings in Company Dechra Pharmaceuticals plc 0 0%
TR-1 Kames Capital Plc . 3,059,054 2.97%
TR-1 Aberdeen Asset Managers Limited (and/or acting for its affiliates) as discretionary investment manager on behalf of multiple managed portfolios Dechra Pharmaceuticals PLC 6,363,032 7.23%
Holdings in Company Dechra Pharmaceuticals PLC 0 0%
TR-1 Dechra Pharmaceuticals PLC 0 5.52%
Holdings in Company Dechra Pharmaceuticals PLC 0 0%
Holdings in Company Dechra Pharmaceuticals PLC 0 0%
Holdings in Company Dechra Pharmaceuticals PLC 0 0%
Holdings in Company Dechra Pharmaceuticals PLC 0 0%
TR-1 Kames Capital Plc . 3,087,417 3.0%
Holdings in Company Dechra Pharmaceuticals PLC 0 0%
TR-1 Dechra Pharmaceuticals PLC 0 5.54%
TR-1 Dechra Pharmaceuticals PLC 0 5.53%
Holdings in Company Dechra Pharmaceuticals PLC 0 0%
Holdings in Company Dechra Pharmaceuticals PLC 0 0%
Holdings in Company Dechra Pharmaceuticals PLC 0 0%
TR-1 Dechra Pharmaceuticals PLC 0 5.54%
Holdings in Company Dechra Pharmaceuticals PLC 0 0%

Elevate your investments